Return to Course LibraryCE InformationPrint Course MaterialsBibliography

Release Date:
July 7, 2016

Expiration Date:
August 1, 2018



Stephanie R. Wilson, MD, FRCPC
Radiologist, Foothills Medical Centre, Calgary
Clinical Professor of Radiology and Medicine
Division of Gastroenterology
University of Calgary
Co-President, International Contrast Ultrasound Society





Equipment Requirements
PC: Win7/Win8, Pentium processor or faster, at least 2GB RAM, Internet Explorer version 10/11, Mozilla FireFox version 33.0.

MAC: OS version 10.8/10.9, Intel processor, at least 2GB RAM, Safari version 6.2, FireFox 33.0


This activity was presented as part of ICUS Grand Rounds

Contrast-enhanced Abdominal Ultrasound
What is it? How does it work? What is it good for? 

This course expires August 1st, 2018

If you want credit, this course must be completed (i.e. view the recording, pass the posttest, AND print the certificate) by no later than July 31st, 2018

Please note, after this course has expired, no aspect of the course will be accessible, including the recorded lecture.

Recording of a live webinar presented on June 16, 2016


A certified, pre-recorded one-hour webinar for radiologists, radiologic technologists, gastroenterologists, nephrologists, urologists, oncologists, and internists.

Format: ARCHIVED Webinar
Credit: 1.0 AMA-PRA Category 1
Credit: 1.0 ARRT Category A+
Tuition:  none

Course Overview
Contrast-enhanced ultrasound (CEUS) imaging requires administration of a microbubble contrast agent and specialized imaging techniques to show sensitive blood flow and tissue perfusion information. CEUS is a safe and easily performed technique that does not require ionizing radiation and has no risk of nephrotoxicity. Although commonly used in Canada, Europe and Asia, the use of microbubble contrast has been off-label and therefore not widely adopted in the U.S.1 The recent Food and Drug Administration approval of a microbubble agent for characterization of focal liver lesions is expected to bring the use of abdominal CEUS into clinical practice in the U.S.

This course covers patient indications for abdominal CEUS; how the contrast medium employs gas-filled microbubbles to improve the visualization of abdominal structures; and the benefits and disadvantages of using abdominal CEUS.

1. Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am J Roentgenol. 2009;193(1):55-60.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe patient indications and abdominal CEUS technique 
  • Discuss how ultrasound contrast agents improve liver mass characterization and visualization of abdominal vascularity and structures
  • Explain how gas-filled microbubbles enhance the reflectivity of sonographic images
  • Outline the evidence and obstacles of CEUS

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to

Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A+ continuing education credit.

How to Participate
There are no fees or prerequisites to participate in this program.

  • Click on the blue link. Complete the precourse questions and SUBMIT.
  • Click on the blue link again to view the recording.

How to Receive Credit

  • Log-in to your account at
  • View the entire educational activity session. At the conclusion of the lecture, close the recording window.
  • Return to the course in your account at
  • From the COURSE HOME page, click the button for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit. You may take the test up to three times.
  • Upon receipt of a passing grade, you will be able to print a certificate of credit from your account at

Stephanie R. Wilson, MD, FRCPC
Radiologist, Foothills Medical Centre, Calgary
Clinical Professor of Radiology and Medicine
Division of Gastroenterology
University of Calgary
Co-President, International Contrast Ultrasound Society

Dr. Wilson graduated with Distinction in Medicine from the University of Alberta and more than 25 years as Professor of Radiology at the University of Toronto before returning to her home in Calgary in 2007. Dr. Wilson has invested her research, academic, and practice pursuits on imaging of the gastrointestinal tract, pancreas and liver.

From 1992 until 2007, Dr. Wilson collaborated with Dr. Peter Burns from University of Toronto/Medical Imaging Research on the investigation of microbubble contrast agents for the evaluation of their use in medical imaging. Their major accomplishments include their investigation of the imaging and diagnosis of tumors of the liver.

Apart from her research pursuits, Dr. Wilson has been the recipient of many prestigious teaching awards including the Colin R. Woolf Award for Excellence in Continuing Education Teaching and the Wightman-Berris Academy Award for Individual Teaching Excellence. On the international stage, Dr. Wilson is the recipient of the prestigious 2011 Jean A. Vezina award for Excellence and Innovation in Radiology from the Société Canadienne-Française de Radiologie (SCFR) and is the 2012 recipient of the Joseph Holmes Pioneer Award from the American Institute of Ultrasound in Medicine and the 2012 recipient of the Lifetime Achievement Award from the Society of Radiologists in Ultrasound (SRU). Dr. Wilson was co-editor of the bell weather two-volume reference text book entitled Diagnostic Ultrasound, with four printings since 1992. This very successful text book continues to serve as a worldwide reference for ultrasound practitioners.

Dr. Wilson was named the first - and the only – female President of the Canadian Association of Radiologists in 1993 and was later awarded with the Canadian Association of Radiologists Gold Medal in 2001 for her contributions to Canadian Radiology.  Dr. Wilson has written over 100 peer reviewed publications and has provided more than 500 international presentations.

Dr.  Wilson runs one of the most advanced and well-known clinical and research facilities for the investigation of microbubble contrast agents for medical imaging in North America, recognized for its accomplishments throughout the world.  She is also a recognized expert in the evaluation of inflammatory bowel disease (IBD) with sonography.  The advancement and choice of ultrasound for imaging of IBD is a major lifetime passion as is the use CEUS for the diagnosis and management of hepatocellular carcinoma.       

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

The faculty has reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Stephanie R. Wilson, MD, FRCPC has no conflicts to disclose.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Trace Hutchison, PharmD                                             Victoria Phoenix, BS

Linda McLean, MS                                                           Jan Schultz, RN, MSN, CCMEP

Samantha Mattiucci, PharmD, CCMEP                    Judi Smelker-Mitchek, RN, BSN                

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

For questions regarding this program, please contact ICPME:
Phone: 607-257-5860 X10

Jointly provided by


This activity is supported by an independent educational grant from GE Healthcare

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.